What does Fulcrum Therapeutics, Inc. do?
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in…
What is Fulcrum Therapeutics, Inc.'s P/E and P/B ratio?
Fulcrum Therapeutics, Inc. has a P/E ratio of -3.0 and a P/B ratio of 0.90.
What is Fulcrum Therapeutics, Inc.'s debt-to-equity ratio?
Fulcrum Therapeutics, Inc. has a debt-to-equity ratio of 0.02.
How much does Fulcrum Therapeutics, Inc. owe compared with what it owns?
Fulcrum Therapeutics, Inc. owes $0.04 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Fulcrum Therapeutics, Inc.'s Positivity rank?
Fulcrum Therapeutics, Inc. is ranked #1,621 of 6,774 companies globally and #385 of 4,000 in United States on PositoAI, with a Positivity Score of 22,493.
Does Fulcrum Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Fulcrum Therapeutics, Inc..
Where can I read the latest news about Fulcrum Therapeutics, Inc.?
Recent headlines about Fulcrum Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Fulcrum Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Fulcrum Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.